Use of fibroblast growth factor 7 (fgf7) and of the receptor...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/74 (2006.01)

Patent

CA 2688480

The use of fibroblast growth factor Fgf7 and of the corresponding receptor Fgfr2b as biomarker candidates for the progesterone receptor antagonist 11 .beta.-(4-acetylphenyl)- 17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafIuoroethyl)estra-4,9-dien-3-one, also known under the designations ZK230211 or ZK-PRA, of the Formula (I) and for antiestrogens is described.

L'invention porte sur l'utilisation du facteur de croissance des fibroblastes Fgf7 et du récepteur correspondant Fgfr2b en tant que candidats de biomarqueur pour l'antagoniste des récepteurs de la progestérone 11 .beta.-(4-acétylphényl)-17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafIuoroéthyl)estra-4,9-diène-3-one, également connu sous les dénominations ZK230211 ou ZK-PRA, représentée par la Formule (I) et pour des anti-AEstrogènes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of fibroblast growth factor 7 (fgf7) and of the receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of fibroblast growth factor 7 (fgf7) and of the receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of fibroblast growth factor 7 (fgf7) and of the receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1756649

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.